CWA Asset Management Group, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
CWA Asset Management Group, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$979,000
+3.4%
22,494
+3.5%
0.09%
+27.8%
Q1 2022$947,000
+36.3%
21,740
+37.9%
0.07%
+41.2%
Q4 2021$695,000
+15.4%
15,7650.0%0.05%
+6.2%
Q3 2021$602,000
-7.7%
15,765
-2.9%
0.05%
-9.4%
Q2 2021$652,000
+124.1%
16,240
+162.3%
0.05%
+12.8%
Q4 2019$291,000
+2.1%
6,192
-7.3%
0.05%
+2.2%
Q3 2019$285,000
+6.3%
6,679
-0.2%
0.05%0.0%
Q2 2019$268,000
-4.6%
6,693
-0.5%
0.05%
-14.8%
Q1 2019$281,000
+3.3%
6,730
-5.3%
0.05%
-14.3%
Q4 2018$272,000
+16.2%
7,110
+21.9%
0.06%
+21.2%
Q3 2018$234,000
-14.3%
5,835
-13.7%
0.05%
-18.8%
Q2 2018$273,000
-2.5%
6,765
-6.1%
0.06%
-7.2%
Q1 2018$280,000
+38.6%
7,203
+26.3%
0.07%
+30.2%
Q4 2017$202,000
-12.9%
5,7030.0%0.05%
-22.1%
Q3 2017$232,000
-0.9%
5,703
+5.0%
0.07%
-8.1%
Q2 2017$234,000
-12.0%
5,433
-14.0%
0.07%
-18.7%
Q1 2017$266,000
+23.7%
6,320
+13.5%
0.09%
-1.1%
Q4 2016$215,000
-99.9%
5,570
-12.1%
0.09%
-39.5%
Q3 2016$273,445,000
+101175.9%
6,340
+1.6%
0.15%
-7.9%
Q2 2016$270,000
+1.5%
6,240
-5.4%
0.16%
-44.8%
Q4 2015$266,0006,5950.30%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2017
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders